Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study.

Source:http://linkedlifedata.com/resource/pubmed/id/12631589

Download in:

View as

General Info

PMID
12631589